Rivaroxaban and Micardis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rivaroxaban (rivaroxaban) and Micardis (telmisartan). Common drug interactions include decreased appetite among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Rivaroxaban and Micardis. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Rivaroxaban?

Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

On Jul, 26, 2026

52 people who take Rivaroxaban and Micardis together, and have interactions are studied.

Rivaroxaban and Micardis drug interactions.

What are the common drug interactions of Rivaroxaban and Micardis, by gender? *:

female:

Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dyspnoea exertional (breathlessness or shortness of breath)
Epistaxis (bleed from the nose)
Gastric mucosal hypertrophy (inflammation and ulcers (breaks on the skin or on the surface of an organ) of the mucosa (inner lining) of the stomach)
Gingival bleeding (bleeding gums)
Hydronephrosis (water inside the kidney)
Metastatic gastric cancer (cancer types can spread to the stomach from other place)
Night sweats (sweating in night)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)

male:

Dizziness
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
Haemorrhage (bleeding)
Adverse event
Angina pectoris (chest pain due to ischemia of the heart muscle)
Asthenia (weakness)
Cardiogenic shock (inadequate circulation of blood)
Dyspnoea (difficult or laboured respiration)
Haematochezia (passage of stools containing blood)
International normalised ratio increased

What are the common drug interactions of Rivaroxaban and Micardis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardiogenic shock (inadequate circulation of blood)
Atrioventricular block (heart block)
Cardiac enzymes increased
Cardiomyopathy (weakening of the heart muscle)
Chest pain
Multi-organ failure (multisystem organ failure)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
Renal failure (kidney dysfunction)
Thrombosis (formation of a blood clot inside a blood vessel)

60+:

Septic shock (shock due to blood infection)
Full blood count decreased
Blood pressure decreased
Cold sweat
Gastrointestinal ischaemia (less blood supply to gastrointestinal tract)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Insomnia (sleeplessness)
Lung neoplasm malignant (cancer tumour of lung)
Anxiety
Bradycardia (abnormally slow heart action)

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 16 people, 30.77%
Diabetes: 9 people, 17.31%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 15.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 13.46%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 11.54%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 11.54%
Type 2 Diabetes: 6 people, 11.54%
Venous Thrombosis Limb (blood clot that forms in a vein in the limb): 5 people, 9.62%
Anaemia (lack of blood): 5 people, 9.62%
Electrolyte Imbalance: 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Rivaroxaban and Micardis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously